Five-Year Efficacy and Safety of Asfotase Alfa Therapy for Adults and Adolescents with Hypophosphatasia
To read more please click on the link below.
Read Article
Related Articles
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Patient of the Month- Elissa S.
Print 🖨 PDF 📄If you would like to donate to Soft Bones in honor of Elissa, please click the button below! Donate Here Where to…
Patient of the Month- Alison S.
Print 🖨 PDF 📄If you would like to donate to Soft Bones in honor of Alison, please click the button below! Donate Here Hi, I’m…
Letter to the Editor: “Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study”
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Responses